The prognostic importance of neuronatin positivity as immunohistochemical in patients with lung adenocarcinoma in the development of brain metastasis
Open Access
- 29 July 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 27653
Abstract
To search the prognostic significance of the neuronatin (NNAT) protein diagnosed with lung adenocarcinoma in the occurence of brain metastasis. Sixty-six of 200 patients diagnosed with lung adenocarcinoma who received radiotherapy (RT) between 2014 and 2017 were included in the study. A total of 66 patients, 33 (50%) with brain pathology and 33 (50%) with lung pathology, were analyzed retrospectively. Furthermore NNAT-immune-reactivity score (IRS) and nuclear positivity were analyzed in terms of pathological factors. In 33 cases where primary tumor pathology was studied, a statistically borderline significant effect was found for the N stage and a statistically significant effect on overall survival (OS) for nuclear positivity. While OS was 7.6 months in nucleus positively stained (PNS) cases, it was 24.4 months in negatively stained (NNS) cases. While the survival of NNAT-IRS positive cases without cranial metastasis was 20.7 months, the survival of the negative group without cranial metastasis was 61.2 months. The survival of cases with PNS without cranial metastasis was 7.1 months, while the survival of cases with NNS results without cranial metastasis was 52.1 months. In cases where intracranial pathologies, the number of intracranial metastases and the presence of extracranial metastases were found to be statistically significant independent factors (p < 0.001, p < 0.001). With NNAT study in initial pathological tissues of patients diagnosed with lung adenocarcinoma, especially nuclear positivity and NNAT-IRS positivity, a strong prediction can be made about the occurrence of brain metastasis.Keywords
Funding Information
- Bilimsel Araştırma Projeleri, Erciyes Üniversitesi (TTU-2020-10075, TTU-2020-10075, TTU-2020-10075, TTU-2020-10075, TTU-2020-10075, TTU-2020-10075)
This publication has 24 references indexed in Scilit:
- Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214Journal of Clinical Oncology, 2011
- Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenomaEndocrine-Related Cancer, 2009
- Coexpression of neuronatin splice forms promotes medulloblastoma growthNeuro-Oncology, 2008
- Neuronatin Expression and Its Clinicopathological Significance in Pulmonary Non-small Cell CarcinomaJournal of Thoracic Oncology, 2007
- High Expressions of Neuronatin Isoforms in Favorable NeuroblastomaJournal of Pediatric Hematology/Oncology, 2007
- Analysis of differentially expressed genes in neuroendocrine carcinomas of the lung.2006
- Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemiaCarcinogenesis, 2002
- The Neuronatin Gene Resides in a “Micro-imprinted” Domain on Human Chromosome 20q11.2Genomics, 2001
- cDNA cloning and mRNA expression analysis of the human neuronatinJournal of Molecular Neuroscience, 1997
- Distribution of Brain MetastasesArchives of Neurology, 1988